retatrutide phase 2 obesity trial VisualAbstract: reduces body weight by 17.5% in patients with Results of a new medication,
Description
Each includes a weekly In-Clinic Houston GLP-1 Injection OR the option for a Monthly GLP-1 Take Home Kit
Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program
How practice might change Given these findings, the initial enthusiasm for the GLP-1s has been tempered
An area affected by lipohypertrophy may feel firmer than the tissue around it and might be: Lipohypertrophy is typically caused by injecting medication into the same area of the skin too often
